The Union Cabinet on Wednesday approved production-linked incentive (PLI) scheme for pharmaceuticals over a period of eight years (FY21-FY29). It will benefit domestic manufacturers, help in creating employment and is expected to contribute to the availability of wider range of affordable medicines for consumers.
The total quantum of incentive under the scheme is about Rs 15,000 crore. The manufacturers of pharmaceutical goods registered in India will be grouped based on their global manufacturing revenue to decide the target elements for the scheme.
The scheme is expected lead to the total incremental sales of Rs 2.94 trillion and exports worth Rs